Page last updated: 2024-08-21

diphenyliodonium and Prostatic Neoplasms

diphenyliodonium has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnold, JR; Grünheck, F; Hescheler, J; Hoffmann, E; Petros, J; Sauer, H; Schwindt, H; Wartenberg, M1

Other Studies

1 other study(ies) available for diphenyliodonium and Prostatic Neoplasms

ArticleYear
Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids.
    FEBS letters, 2005, Aug-15, Volume: 579, Issue:20

    Topics: Ascorbic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biphenyl Compounds; Cell Line, Tumor; Drug Resistance, Multiple; Free Radical Scavengers; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Multidrug Resistance-Associated Proteins; NADPH Oxidase 1; NADPH Oxidases; Onium Compounds; Prostatic Neoplasms; Reactive Oxygen Species; Spheroids, Cellular; Sulfones; Transcription Factors; Vitamin E

2005